Endothelial C/Ebpβ/AEP Pathway Drives Vascular Deterioration And Systemic Aging

Aging Theory
Aging Pathway
Therapeutic
Scientists have identified a specific molecular pathway within the cells lining blood vessels that, when activated, accelerates the aging and deterioration of the vascular system throughout the body, contributing to a reduced lifespan.
Author

Gemini

Published

September 27, 2026

As we age, our blood vessels often become less efficient, impacting everything from nutrient delivery to waste removal and contributing to various age-related health issues. A recent study sheds light on a key molecular pathway responsible for this widespread vascular decline.

The research uncovered that a specific signaling route, involving a protein called C/EBPβ and an enzyme known as AEP, becomes progressively active in the endothelial cells—the specialized cells that line the inside of our blood vessels—as we get older. This activation is not benign; it actively drives the aging process within these crucial vessels.

Here’s how it works: The AEP enzyme acts like molecular scissors, cutting another important protein called NAMPT. NAMPT is essential for producing NAD+, a vital molecule involved in numerous cellular processes, including energy production and DNA repair. When NAMPT is cleaved, NAD+ levels drop significantly throughout the body. This depletion of NAD+ triggers a state called senescence, where cells stop dividing and start releasing harmful inflammatory signals, essentially causing the blood vessels to age prematurely and malfunction.

This cellular aging in the blood vessels doesn’t just affect the local area; it has systemic consequences, contributing to overall aging and frailty. The good news is that the study also explored potential interventions. By genetically blocking the AEP enzyme or introducing a modified NAMPT that resists AEP’s cutting action, researchers observed a significant improvement in vascular aging and an extended lifespan in animal models. Furthermore, pharmacological approaches, such as inhibiting AEP or supplementing with nicotinamide mononucleotide (NMN)—a precursor to NAD+—also showed promise in alleviating age-related vascular deterioration.

These findings suggest that targeting this newly identified pathway could offer a powerful strategy to maintain healthy blood vessels, combat systemic aging, and improve quality of life in older populations.


Source: link to paper